India
· Delayed Price · Currency is INR Mangalam Drugs & Organics Statistics
Total Valuation
NSE:MANGALAM has a market cap or net worth of INR 1.25 billion. The enterprise value is 2.19 billion.
| Market Cap | 1.25B |
| Enterprise Value | 2.19B |
Important Dates
The last earnings date was Friday, May 30, 2025.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 15.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | -6.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 6.88M |
Valuation Ratios
The trailing PE ratio is 18.61.
| PE Ratio | 18.61 |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | 5.58 |
| P/OCF Ratio | 2.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.10, with an EV/FCF ratio of 9.77.
| EV / Earnings | 32.54 |
| EV / Sales | 0.69 |
| EV / EBITDA | 6.10 |
| EV / EBIT | 11.38 |
| EV / FCF | 9.77 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.04 |
| Quick Ratio | 0.22 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.69 |
| Debt / FCF | 4.30 |
| Interest Coverage | 1.29 |
Financial Efficiency
Return on equity (ROE) is 4.72% and return on invested capital (ROIC) is 4.92%.
| Return on Equity (ROE) | 4.72% |
| Return on Assets (ROA) | 3.43% |
| Return on Invested Capital (ROIC) | 4.92% |
| Return on Capital Employed (ROCE) | 10.99% |
| Revenue Per Employee | 7.35M |
| Profits Per Employee | 155,572 |
| Employee Count | 432 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.75% in the last 52 weeks. The beta is 0.13, so NSE:MANGALAM's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -22.75% |
| 50-Day Moving Average | 78.59 |
| 200-Day Moving Average | 104.91 |
| Relative Strength Index (RSI) | 49.83 |
| Average Volume (20 Days) | 33,273 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MANGALAM had revenue of INR 3.18 billion and earned 67.21 million in profits. Earnings per share was 4.25.
| Revenue | 3.18B |
| Gross Profit | 1.50B |
| Operating Income | 192.16M |
| Pretax Income | 47.86M |
| Net Income | 67.21M |
| EBITDA | 358.23M |
| EBIT | 192.16M |
| Earnings Per Share (EPS) | 4.25 |
Balance Sheet
The company has 25.89 million in cash and 962.30 million in debt, giving a net cash position of -936.41 million.
| Cash & Cash Equivalents | 25.89M |
| Total Debt | 962.30M |
| Net Cash | -936.41M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 100.32 |
| Working Capital | 73.84M |
Cash Flow
In the last 12 months, operating cash flow was 425.94 million and capital expenditures -202.01 million, giving a free cash flow of 223.93 million.
| Operating Cash Flow | 425.94M |
| Capital Expenditures | -202.01M |
| Free Cash Flow | 223.93M |
| FCF Per Share | n/a |
Margins
Gross margin is 47.30%, with operating and profit margins of 6.05% and 2.12%.
| Gross Margin | 47.30% |
| Operating Margin | 6.05% |
| Pretax Margin | 1.51% |
| Profit Margin | 2.12% |
| EBITDA Margin | 11.28% |
| EBIT Margin | 6.05% |
| FCF Margin | 7.05% |
Dividends & Yields
NSE:MANGALAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.09% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.37% |
| FCF Yield | 17.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |